Equities

Progyny Inc

PGNY:NSQ

Progyny Inc

Actions
Health CareHealth Care Providers
  • Price (USD)14.99
  • Today's Change1.01 / 7.19%
  • Shares traded1.00
  • 1 Year change-54.40%
  • Beta1.3487
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Progyny Inc grew revenues 38.34% from 786.91m to 1.09bn while net income improved 104.35% from 30.36m to 62.04m.
Gross margin21.68%
Net profit margin5.03%
Operating margin5.75%
Return on assets8.26%
Return on equity12.05%
Return on investment11.63%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Progyny Inc fell by 22.78m. However, the company earned 188.81m from its operations for a Cash Flow Margin of 17.34%. In addition the company used 200.53m on investing activities and also paid 11.07m in financing cash flows.
Cash flow per share0.6117
Price/Cash flow per share22.44
Book value per share4.92
Tangible book value per share4.73
More ▼

Balance sheet in USDView more

Progyny Inc uses little or no debt in its capital structure.
Current ratio2.62
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.